What's Keeping CAR T-Cell Therapies From the Outpatient Setting?
Although these therapies were initially conceived of and developed as inpatient therapies, interest is growing in extending chimeric antigen receptor T-cell therapies to the outpatient setting.
Predictive Value Examined Among Genomic Tests for Breast Cancer
Multiple gene signature assays have been developed that supply prognostic information for decisions on adjuvant chemotherapy and whether therapy should be of extended duration.